Division News

Often, patients with chronic illnesses are prescribed a number of medications to take throughout their day, but experts suggest, close to half of those people don’t take their medications as directed by their doctors.

Eugene Washington, MD, chancellor for health affairs at Duke University and president and CEO of the Duke University Health System, and Nancy Andrews, MD, PhD, dean of the Duke University School of Medicine, announced this week the launch of the Duke Clinical and Translational Science Institute (CTSI).

Duke General Internal Medicine is announcing a new awards program to honor the outstanding achievements of our Division Faculty and Staff Members in Clinical Care, Education, Research, Implementation and Professionalism. 

Keisha Bentley-Edwards, PhD, joined our division in July. She works at the DuBois Cook Center on Social Equity while also conducting research and assisting in the Duke Center for Community and Population Health Improvement. To get to know Dr. Bentley-Edwards a little more, we asked her the following questions:

This isn’t the first time, and I’m sure it won’t be the last either!

If you have been paying close attention to the 2016 Olympic games, then you may have noticed some strange red circle marks on some of the competing athletes. These are a result from a practice that is supposed to aid recovery and boost performance referred to as “cupping”, and Duke GIM’s own Adam Perlman, MD, executive director for Duke Integrative Medicine, knows quite a bit about it.

Many Americans these days are finding ways to treat symptoms using a nondrug treatment such as acupuncture, chiropractic care, or massage therapy. Just recently, Arthritis Today magazine, featured an article on these treatments called “Hands-on Healing”.

An anonymous donor has given $60,000 to the Department of Medicine to support the Internal Medicine Residency Program, said Magnus Ohman, MD, vice chair for development and innovation.

The donor made this gift in honor of Brian Wolf, MD, medical instructor in the Department of Medicine (General Internal Medicine) and provider in Duke Signature Care.

Type 2 diabetic kidney disease (DKD) is the major cause of end-stage renal disease (ESRD) in the United States and is a growing global health concern accounting for over half of all new cases and over $10 billion in medical expenditures each year. While many people with diabetes do not develop kidney disease, those who do have very poor outcomes. Among those with DKD, about 60% have uncontrolled hypertension that increases the risk of ESRD, cardiovascular events and death.

Typically editorial board members for medical journals are chosen from the population of excellent reviewers. No exception for Virginia Wang, PhD who recently accepted an invitation to be on the editorial board of BMC Nephrology as Associate Editor of the Epidemiology and Outcomes Section.